This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
Product | Active Ingredient(s) |
Caverject 20mcg Powder and Solvent for Solution for Injection PA0822/115/003 Pfizer Healthcare Ireland | Alprostadil |
Chloromycetin 0.5% w/v Redidrops Eye Drops PA1142/021/001 Amdipharm Limited | Chloramphenicol |
Fucidin Cream PA0046/004/012 Leo Laboratories Limited | Fusidic acid |
Ikervis 1 mg/ml Eye Drops EU/1/15/990/001 Santen OY | Ciclosporin |
Thamicarb 84mg/ml Oral Solution PA22697/017/001 Syri Pharma Limited t/a Thame Laboratories | Sodium hydrogen carbonate |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
Product | Active Ingredient(s) |
Adenocor 3 mg/ml Solution for Injection PA0540/139/001 Sanofi-Aventis Ireland Limited T/A SANOFI | Adenosine |
Adenosine 3mg/ml Solution for Injection in Pre Filled Syringe PA2059/004/001 Fresenius Kabi Deutschland GmbH | Adenosine |
Atorvastatin Teva 10mg Film Coated Tablets PA0749/110/001 Teva Pharma B.V. | Atorvastatin |
Azyter 15 mg/g Eye Drops Solution PA1107/004/001 Laboratoires Thea | Azithromycin |
Azzalure 125 Speywood Units, Powder for Solution for Injection PA1613/001/001 Ipsen Pharma | Clostridium Botulinum Toxin Type A |
Dobutamine 12.5mg/ml Concentrate for Solution for Infusion PA0073/137/001 Mercury Pharmaceuticals (Ireland) Ltd | Dobutamine |
Isomel 60mg Prolonged Release Tablet PA2261/002/001 Dexcel Pharma GmbH | Isosorbid-5-mononitrat |
Kamiren 4mg Prolonged-Release Tablets PA1347/038/001 KRKA, d.d., Novo mesto | Doxazosin |
Ketalar 50 mg/ml Solution for Injection/Infusion PA0822/013/002 Pfizer Healthcare Ireland | Ketamine |
Lactulose Fresenius 670mg/ml Oral Solution PA0773/003/001 Fresenius Kabi Austria GmbH | Lactulose |
Lansoprazole Teva Pharma 30mg Gastro-Resistant Hard Capsules PA1986/008/002 Teva B.V. | Lansoprazole |
Lycimor 300mg Hard Capsules PA1986/118/001 Teva B.V. | Lymecycline |
Raporsin 4mg Prolonged Release Tablets PA2315/005/001 Accord Healthcare Ireland Ltd. | Doxazosin |
Senokot 7.5 mg/5 ml Syrup PA0979/016/003 Reckitt Benckiser Ireland Ltd | Sennoside b |
Solpadeine Capsules 24 pack PA1186/011/002 Chefaro Ireland DAC | Paracetamol, codeine & caffeine |
Sotoger 80mg Tablets PA0577/021/001 McDermott Laboratories Ltd., T/A Gerard Laboratories | Sotalol |
Tarceva 100mg Film Coated Tablets EU/1/05/311/002 Roche Registration GmbH | Erlotinib |
Tyvense 30mg Capsules PA0540/139/001 Takeda Pharmaceuticals International AG Ireland Branch | Lisdexamfetamine |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.